Medicine

Follow
Elderly woman with type 2 diabetes walking healthily outdoors, holding semaglutide pen, with subtle ENDO 2026 study charts in background
Image generated by AI

Study presented at ENDO 2026 links semaglutide to fewer fractures in people with type 2 diabetes

Reported by AI Image generated by AI Fact checked

Semaglutide was associated with a lower rate of bone fractures and greater reductions in body mass index among adults with type 2 diabetes, according to a retrospective analysis presented at the Endocrine Society’s ENDO 2026 meeting in Chicago.

Many adults with type 2 diabetes who pause GLP-1 medications such as semaglutide (Ozempic) later resume treatment, according to research scheduled for presentation at ENDO 2026 in Chicago.

Reported by AI

A major new analysis of nearly 154,000 adults shows that calcium and vitamin D supplements provide little to no protection against fractures or falls for most older people. The findings, published in The BMJ, challenge long-standing recommendations for routine use of these supplements.

New data presented at the European Renal Association’s 63rd Congress in Glasgow and published in three major medical journals found that finerenone slowed kidney-function decline in adults with chronic kidney disease (CKD) without diabetes and reduced the risk of a combined kidney-and-cardiovascular outcome. A separate pooled analysis that combined results across finerenone studies also reported fewer kidney and heart-failure events in a broader CKD population.

Reported by AI

Women taking GLP-1 medications such as Ozempic and Wegovy showed about 30 percent lower odds of developing breast cancer in a large observational study.

Turkey has built a billion-dollar hair transplant industry through ongoing innovation in medical equipment and algorithms.

Reported by AI

Cancer cases in Hong Kong have more than doubled since 1983, yet the age-standardised death rate has nearly halved to 71.1 per 100,000 people by 2023.

 

 

 

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline